Drug Shortage Report for MYLAN-TADALAFIL

Last updated on 2019-08-23 History
Report ID 45590
Drug Identification Number 02410648
Brand name MYLAN-TADALAFIL
Common or Proper name TADALAFIL
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) TADALAFIL
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 28 BL
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-10-29
Actual start date 2018-10-29
Estimated end date 2019-08-22
Actual end date 2019-08-22
Shortage status Resolved
Updated date 2019-08-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v58 2019-08-23 French Compare
v57 2019-08-23 English Compare
v56 2019-08-23 English Compare
v55 2019-08-15 French Compare
v54 2019-08-15 English Compare
v53 2019-06-18 French Compare
v52 2019-06-18 English Compare
v51 2019-04-03 French Compare
v50 2019-04-03 English Compare
v49 2019-03-28 French Compare
v48 2019-03-28 English Compare
v47 2019-02-01 French Compare
v46 2019-02-01 English Compare
v45 2018-11-13 French Compare
v44 2018-11-13 English Compare
v43 2018-10-30 English Compare
v42 2018-10-29 French Compare
v41 2018-10-29 English Compare
v40 2018-10-27 English Compare
v39 2018-10-23 French Compare

Showing 1 to 20 of 58